Elevated serum testosterone levels and risk of hepatocellular carcinoma
- PMID: 8381328
Elevated serum testosterone levels and risk of hepatocellular carcinoma
Abstract
Serum samples of 9691 male adults had been collected and frozen for a prospective study of hepatocellular carcinoma in Taiwan. After an average follow-up period of 4.6 years, testosterone levels in the stored serum were measured by radioimmunoassay using commercial kits for 35 cases of newly developed hepatocellular carcinoma, 63 hepatitis B surface antigen-negative and 77 hepatitis B surface antigen-positive matched controls. Elevated testosterone levels were found to be associated with an increased risk of hepatocellular carcinoma. The association remained significant after the adjustment for effects of other hepatocellular carcinoma risk factors, including hepatitis B surface antigen carrier status, positivity of serum antibody to hepatitis C virus, cigarette smoking, alcohol drinking, past liver disease history, and dietary habits. The multivariate-adjusted relative risk of hepatocellular carcinoma for men with testosterone levels in the upper tertile was 4.1 (95% confidence interval = 1.3-13.2) compared with those having levels in the middle or lower tertiles (P = 0.016). The results consistent with those observed in animal experiments support the hypothesis that testosterone plays a role in the etiology of human hepatocellular carcinoma.
Similar articles
-
Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma.Cancer Res. 1995 Mar 15;55(6):1301-5. Cancer Res. 1995. PMID: 7882326
-
Serum testosterone:estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients.Cancer Res. 2000 Sep 15;60(18):5106-10. Cancer Res. 2000. PMID: 11016636
-
Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan.Cancer Res. 1991 Oct 15;51(20):5621-5. Cancer Res. 1991. PMID: 1655259
-
Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.Princess Takamatsu Symp. 1995;25:27-32. Princess Takamatsu Symp. 1995. PMID: 8875606 Review.
-
Hepatocellular carcinoma and type B hepatitis.Clin Gastroenterol. 1980 Jan;9(1):117-34. Clin Gastroenterol. 1980. PMID: 6249525 Review. No abstract available.
Cited by
-
The expression of estrogen receptors in hepatocellular carcinoma in Korean patients.Yonsei Med J. 2006 Dec 31;47(6):811-6. doi: 10.3349/ymj.2006.47.6.811. Yonsei Med J. 2006. PMID: 17191310 Free PMC article.
-
Hepatocellular carcinoma: A global view.Nat Rev Gastroenterol Hepatol. 2010 Aug;7(8):448-58. doi: 10.1038/nrgastro.2010.100. Epub 2010 Jul 13. Nat Rev Gastroenterol Hepatol. 2010. PMID: 20628345 Free PMC article. Review.
-
Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA.EMBO J. 1994 Sep 15;13(18):4241-50. doi: 10.1002/j.1460-2075.1994.tb06744.x. EMBO J. 1994. PMID: 7925269 Free PMC article.
-
Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma.Am J Hum Genet. 1996 Jul;59(1):128-34. Am J Hum Genet. 1996. PMID: 8659516 Free PMC article.
-
Testosterone strongly enhances azoxymethane/dextran sulfate sodium-induced colorectal cancer development in C57BL/6 mice.Am J Cancer Res. 2021 Jun 15;11(6):3145-3162. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249451 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous